RPHM

Reneo Pharmaceuticals, Inc.

1.66 USD
+0.02 (+1.22%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Reneo Pharmaceuticals, Inc. stock is up 4.4% since 30 days ago. The next earnings date is Mar 25, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 2 March’s closed higher than February.

About Reneo Pharmaceuticals, Inc.

Reneo Pharmaceuticals, Inc. focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial.